OXFORD EXPRESSION TECHNOLOGIES LIMITED

Active Newbury

Research and experimental development on biotechnology

18 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
O

OXFORD EXPRESSION TECHNOLOGIES LIMITED

Research and experimental development on biotechnology

Founded 12 Jul 2006 Active Newbury, United Kingdom 18 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 7 Apr 2026 Next due 31 Jul 2026 3 months remaining
Confirmation Submitted 18 Feb 2026 Next due 2 Mar 2027 10 months remaining
Net assets £3M £588K 2024 year on year
Total assets £3M £848K 2024 year on year
Total Liabilities £341K £261K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

2 Communications Road Greenham Business Park Newbury Berkshire RG19 6AB United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for OXFORD EXPRESSION TECHNOLOGIES LIMITED (05874405), an active life sciences and medical technology company based in Newbury, United Kingdom. Incorporated 12 Jul 2006. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£2.01M

Increased by £235.04k (+13%)

Net Assets

£2.61M

Increased by £587.81k (+29%)

Total Liabilities

£340.95k

Increased by £260.50k (+324%)

Turnover

N/A

Employees

18

Increased by 2 (+13%)

Debt Ratio

12%

Increased by 8 (+200%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 3

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (8)

Oxford Brookes University
31.2%
43,557
Edward Bernard
21.0%
29,333

Persons with Significant Control

Persons with Significant Control (3)

3 Active 2 Ceased

Professor Robert David Possee

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB September 1956
Nature of Control
  • Significant Influence Or Control

Mr Brendan Casey

Irish

Active
Notified 7 Jul 2025
Residence England
DOB October 1966
Nature of Control
  • Voting Rights 25 To 50 Percent

Prof Linda Anne King

British

Active
Notified 6 Apr 2016
Residence England
DOB October 1959
Nature of Control
  • Significant Influence Or Control

Edward Bernard

Ceased 8 Nov 2022

Ceased

Professor Alistair David Fitt

Ceased 7 Jul 2025

Ceased

Group Structure

Group Structure

OXFORD EXPRESSION TECHNOLOGIES LIMITED Current Company
OET LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Apr 2026AccountsAnnual accounts made up to 2025-10-31
18 Feb 2026Confirmation StatementConfirmation statement made on 2026-02-16 with updates
17 Feb 2026OfficersChange to director Dr Linda Anne King on 2026-02-01
17 Feb 2026Persons With Significant ControlChange to Prof Linda Anne King as a person with significant control on 2026-02-01
5 Sept 2025CapitalCapital Return Purchase Own Shares
7 Apr 2026 Accounts

Annual accounts made up to 2025-10-31

18 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-02-16 with updates

17 Feb 2026 Officers

Change to director Dr Linda Anne King on 2026-02-01

17 Feb 2026 Persons With Significant Control

Change to Prof Linda Anne King as a person with significant control on 2026-02-01

5 Sept 2025 Capital

Capital Return Purchase Own Shares

Recent Activity

Latest Activity

Annual accounts made up to 2025-10-31

2 weeks ago on 7 Apr 2026

Confirmation statement made on 2026-02-16 with updates

2 months ago on 18 Feb 2026

Change to director Dr Linda Anne King on 2026-02-01

2 months ago on 17 Feb 2026

Change to Prof Linda Anne King as a person with significant control on 2026-02-01

2 months ago on 17 Feb 2026

Capital Return Purchase Own Shares

7 months ago on 5 Sept 2025